Trial Information
Current as of January 17, 2025
Completed
Keywords
ClinConnect Summary
The objectives are:
* to evaluate the technical success of the device
* to evaluate performance parameters (accuracy measures, adjustements, post-intervention ablation success, local tumor recurrence)
* to evaluate the safety of the device
25 subjectsare planned and will undergo an intervention, during which the clinician will use the EPIONE device
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient ≥18 years old,
- • Patient for whom a percutaneous CT-guided intervention in lung has been prescribed and agreed by a multidisciplinary team of radiologists, surgeons and clinicians,
- • Patient with a signed informed consent form.
- • Patient covered by a social security system.
- Exclusion Criteria:
- • Patient unable to undergo general anesthesia,
- • Pregnant or nursing female, confirmed before the intervention
- • Patient already participating in another clinical study
Trial Officials
Baptiste BONNET, MD
Principal Investigator
Gustave Roussy, Cancer Campus, Grand Paris
About Quantum Surgical
Quantum Surgical is a pioneering medical technology company dedicated to advancing minimally invasive surgical solutions through innovative robotic systems. With a strong focus on improving patient outcomes and enhancing surgical precision, Quantum Surgical develops cutting-edge tools that empower healthcare professionals in the treatment of complex conditions. The company is committed to advancing clinical research and fostering collaboration in the medical community, striving to set new standards in surgical care and patient safety. Through rigorous clinical trials and a dedication to innovation, Quantum Surgical aims to transform the landscape of surgical procedures for the benefit of patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Marseille, , France
Villejuif, , France
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
Similar Trials